Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 2/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.35 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | PGD | P52209 | 1/20 | 0.34 |
| ▸ | BHMT | Q93088 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL330114 | 1.00 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| SCHEMBL2611908 | 1.00 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| Water SCHEMBL30283282 | 0.98 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| Hydrochloric Acid SCHEMBL6700549 | 0.98 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| Hydrochloric Acid SCHEMBL6700554 | 0.98 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| Hydrochloric Acid SCHEMBL25276889 | 0.98 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| SCHEMBL28833837 | 0.98 | LTA4H (0.36) | LTA4HNOS1NOS3NOS2SLC7A5 | |
| Hydrochloric Acid SCHEMBL30947817 | 0.86 | KDM4E (0.38) | GRIK1PGDBHMTGABRR1LMNA | |
| SCHEMBL17732318 | 0.86 | PGD (0.37) | GRIK1PGDBHMTGABRR1LMNA | |
| SCHEMBL29720991 | 0.85 | DGAT1 (0.34) | NOS1NOS3NOS2SLC7A5GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4703370-A1 | AMINO ACID-DERIVED CERAMIDE, SYNTHESIS METHOD THEREFOR AND USE THEREOF | Shenzhen Dikeman Biotechnology Co., Ltd. (CN) | 2026-03-04 | — | — | EP | claimed |
| CN-116444393-B | Anti-glycation amino acid derivative and synthesis method and application thereof | 深圳市迪克曼生物科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119470406-A | Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof | 山东新华莎罗雅生物技术有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119350189-A | Method for preparing N-methyl-N-benzyloxycarbonyl-L-aspartic acid-4-tert-butyl ester | 上海农林职业技术学院 | 2025-01-24 | — | — | CN | claimed |
| CN-119241385-A | Beta-acyloxy enamide derivative and preparation method and application thereof | 江西师范大学 | 2025-01-03 | — | — | CN | claimed |
| WO-2024222082-A1 | AMINO ACID-DERIVED CERAMIDE, SYNTHESIS METHOD THEREFOR AND USE THEREOF | 深圳市迪克曼生物科技有限公司 | 2024-10-31 | — | — | WO | claimed |
| CN-116444393-A | Anti-glycation amino acid derivative and synthesis method and application thereof | 深圳市迪克曼生物科技有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-116143881-A | Preparation method of bumenopeptide | 深圳市健元医药科技有限公司 | 2023-05-23 | — | — | CN | claimed |
| CN-113461574-B | Fmoc-AA-NH 2 Preparation method of (1) | 成都郑源生化科技有限公司 | 2023-04-11 | — | — | CN | claimed |
| CN-113461574-A | Fmoc-AA-NH2Preparation method of (1) | 成都郑源生化科技有限公司 | 2021-10-01 | — | — | CN | claimed |
| CN-102076342-B | Novel nitroso compounds as nitroxyl donors and methods of use thereof | CARDIOXYL PHARMACEUTICALS INC | 2015-06-10 | — | — | CN | claimed |
| US-20120148631-A1 | PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY | INTEZYNE TECHNOLOGIES, INCORPORATED (US) | 2012-06-14 | — | — | US | claimed |
| EP-1656390-A2 | COMPOSITIONS OF LIPOPEPTIDE ANTIBIOTIC DERIVATIVES AND METHODS OF USE THEREOF | MIGENIX INC. (CA) | 2006-05-17 | — | — | EP | claimed |
| US-20050153876-A1 | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | MIGENIX INC. (CA) | 2005-07-14 | — | — | US | claimed |
| WO-2005000878-A2 | COMPOSITIONS OF LIPOPEPTIDE ANTIBIOTIC DERIVATIVES AND METHODS OF USE THEREOF | MIGENIX INC. (CA) | 2005-01-06 | — | — | WO | claimed |
| EP-4724068-A2 | COMPOUNDS SPECIFIC TO GRANZYME B AND USES THEREOF | Cytosite Biopharma Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4724061-A2 | PRODRUGS FOR COMPOUNDS SPECIFIC TO GRANZYME B AND USES THEREOF | Cytosite Biopharma Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-0468497-A2 | Peptide-antagonists of bombesin/GRP | MERRELL PHARMACEUTICALS INC. (US) | 1992-01-29 | — | — | EP | disclosed |
| EP-0434979-A1 | Peptide derivatives useful as antagonists of bombesin and gastrin-releasing peptide | MERRELL DOW PHARMACEUTICALS INC. (US) | 1991-07-03 | — | — | EP | disclosed |
| US-4351764-A | Process for the selective formation of disulfide bridges in polypeptides and therapeutic compositions | der Wissenschaften e.V. Max-Planck-Gesellschaft zur/Forderung (DE) | 1982-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120148631-A1 | PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY | PARN, PUF60, PARG | LTA4H 4344/4885NOS1 3652/4885NOS3 2492/4885 |
| US-20050153876-A1 | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | NRDC, NOD2, NGLY1 | LTA4H 135/4885NOS1 3908/4885NOS3 3536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.